Atlas Trials

Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer

Clinical trial NCT05800574 · RECRUITING

Trial details

NCT number
NCT05800574
Sponsor
Fox Chase Cancer Center
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Oropharynx Cancer
Start date
2023-03-14
Primary completion
2026-09-23
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.